Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation

Transplantation

Volumn 83, Issue 6, 2007, Pages 706-711

  Heinemann, Falko M ^a   Rebmann, Vera ^a   Witzke, Oliver ^a   Philipp, Thomas ^a   Broelsch, Christoph E ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Allograft failure; Renal transplantation; sCD30

Indexed keywords

CD30 ANTIGEN; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; CADAVER KIDNEY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; ANTIGENS, CD30; BIOPSY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34147185263     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000255326.27474.a4     Document Type: Article

References (19)

1. Shenton BK. The detection and relevance of pretransplant antibodies. Transplant Immunol 1994; 2: 135.
2. Opelz G, Wujciak T. Cadaveric kidneys should be allocated according to the HLA match. Transplant Proc 1995; 27: 93.
3. Pelzl S, Opelz G, Weisel M, et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 2002; 73: 3.
4. Susal C, Pelzl S, Dohler B, Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002; 13: 1650.
5. Pelzl S, Opelz G, Daniel V, et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 2003; 75: 421.
6. Weimer R, Süsal C, Yildiz S, et al. sCD30 and Neopterin as risk factors of chronic renal transplant rejection: Impact of Cyclosporine A, Tacrolimus, and Mycophenolate Mofetil. Transplant Proc 2005; 37: 1776.
7. Rajakariar R, Jivanji N, Varagunam M, et al. High Pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 2005; 5: 1922.
8. Süsal C, Pelzl S, Opelz G. Strong HLA matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 2003; 76: 1231.
9. Matinlauri IH, Kyllönen LEJ, Salmela KT, et al. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadeveric kidney transplantations. Transplantation 2005; 80: 1809.
10. Bauwens AM, van de Graaf EA, van Ginkel WG, van Kessel DA, Otten HG. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2006; 25: 416.
11. Kim KH, Oh EJ, Jung ES, et al. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection. Transplant Proc 2006; 38: 1429.
12. Frisaldi E, Conca R, Magistroni P, et al. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation. Transplantation 2006; 81: 1153.
13. McMillan SA, McDonnel GV, Douglas JP, et al. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis. Neurology 1998; 51: 1156.
14. Nakao K, Nagake Y, Okamoto A, et al. Serum levels of soluble CD26 and CD30 in Patients on hemodialysis. Nephron 2002; 91: 215.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
16. Pellegrin I, Garrigue I, Ekouevi D, et al. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis 2000; 182: 36.
17. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
19. Cinti P, Pretagostini R, Arpino A, et al. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 2005; 79: 599.